Martha Grogan, M.D.

Assistant Professor, Cardiologist and Internist
Mayo Clinic Rochester

Poster(s):

• (T1130-05-32) Acoramidis Improved Clinical Outcomes, Function, Quality of Life and NT-proBNP in Patients with Transthyretin Amyloid Cardiomyopathy Regardless of Atrial Fibrillation Status at Baseline
  Tuesday, November 11, 2025

  11:30 AM - 12:30 PM CT

• (M1230-05-28) Acoramidis Reduces All-Cause Mortality and First Cardiovascular Hospitalization in Patients with Variant Transthyretin Amyloid Cardiomyopathy: Results from the ATTRibute-CM Study
  Monday, November 10, 2025

  12:30 PM - 1:30 PM CT

• (M1330-05-28) Acoramidis Effect on All-Cause Mortality in Patients with p.V142I (V122I) Variant ATTR-CM: Findings from the ATTRibute-CM Study
  Monday, November 10, 2025

  1:30 PM - 2:30 PM CT